The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.
<h4>Introduction</h4>The efficacy of treatment with selective serotonin reuptake inhibitors in patients with major depressive disorder (MDD) can differ depending on the patient's serotonin transporter-linked polymorphic region (5-HTTLPR) genotype, and the effects of varying plasma c...
Guardado en:
Autores principales: | Tetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, Shoko Tsuchimine, Masamichi Ishioka, Ayako Kaneda, Norio Sugawara, Sunao Kaneko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0574598e14754dafbe870e7926792996 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of personality on the association between paroxetine plasma concentration and response
por: Tomita T, et al.
Publicado: (2018) -
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response [Corrigendum]
por: Tomita T, et al.
Publicado: (2014) -
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki A, et al.
Publicado: (2014) -
Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine?
por: Norio Sugawara, et al.
Publicado: (2021) -
The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo S, et al.
Publicado: (2015)